Centene Corporation logo

Centene Corporation (CNC)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
70. 51
+0.36
+0.506%
Pre Market
$
71. 00
+0.49 +0.6949%
32.29B Market Cap
16.46 P/E Ratio
- Div Yield
4.5M Volume
6.67 Eps
$ 70.16
Previous Close
Add Transaction
Day Range
69.87 71
Year Range
31.63 71.01
Want to track CNC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Centene Reports $1 Billion Loss Amid Health Insurer Cost Issues

Centene Reports $1 Billion Loss Amid Health Insurer Cost Issues

Health insurer Centene reported a loss of more than $1 billion in the fourth quarter as the company continued to struggle with rising healthcare costs in the government-subsidized health plans it administers and sells.

Forbes | 8 months ago
Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?

Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?

CNC heads into Q4 earnings with revenue growth expected, but declining membership and higher medical costs cloud the outlook.

Zacks | 8 months ago
Centene Expands Palliative Care Access in Ohio Through Tuesday Health

Centene Expands Palliative Care Access in Ohio Through Tuesday Health

CNC teams up with Tuesday Health to expand palliative care in Ohio, blending in-person and virtual support.

Zacks | 8 months ago
CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

Centene expands its Medicaid strategy by partnering with Cityblock Health to serve 10,000 Illinois members with 24/7 wrap-around care.

Zacks | 9 months ago
Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm?

Centene Jumps 16.3% in 3 Months: A Comeback or Calm Before the Storm?

CNC shares jump 16.3% in three months, but high medical costs and thin margins keep the recovery debate alive.

Zacks | 9 months ago
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026

Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026

Health insurers are regaining pricing control and margin visibility, putting UnitedHealth, CVS Health and Centene back in focus as managed care regains its pulse.

Zacks | 10 months ago
3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures

3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures

The Medical-HMO industry pursues growth through M&A and tech innovation, aided by easing interest rates, but faces headwinds from rising medical costs, regulatory shifts and a shortage of healthcare professionals. UNH, HUM and CNC are likely to navigate industry storms.

Zacks | 10 months ago
Centene's Recovery Still Has Legs - Further Margin Expansion Ahead

Centene's Recovery Still Has Legs - Further Margin Expansion Ahead

CNC remains a Great Buy, thanks to its promising multi-year margin recovery prospects arising from the drastically raised premiums by the mid 30%s. While the management already expects to see "some degree of membership attrition," I am of the opinion that this is an inevitable (and temporary) pain for its future margin recovery. The raised FY2025 guidance and the bottoming in its FQ3'25 HBR imply the worst may be behind us, with FY2026 likely to bring forth improved numbers.

Seekingalpha | 10 months ago
Anticipation of This Trump Proposal Is Sending Health Insurance Stocks Higher Monday

Anticipation of This Trump Proposal Is Sending Health Insurance Stocks Higher Monday

Shares of several major health insurers surged Monday following reports President Donald Trump could be set to unveil a healthcare proposal that would extend Affordable Care Act subsidies.

Investopedia | 10 months ago
Centene Stock Jumps 6.2% as Reddit Traders Buy the Dip Analysts Won't Touch

Centene Stock Jumps 6.2% as Reddit Traders Buy the Dip Analysts Won't Touch

Shares of Centene Corporation (NYSE: CNC) have climbed 6.2% from their November 10 low of $34.25.

247wallst | 11 months ago
Centene Corporation (CNC) Presents at UBS Global Healthcare Conference 2025 Transcript

Centene Corporation (CNC) Presents at UBS Global Healthcare Conference 2025 Transcript

Centene Corporation ( CNC ) UBS Global Healthcare Conference 2025 November 11, 2025 10:15 AM EST Company Participants Sarah London - CEO & Director Andrew Asher - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division Well, hello, everyone. Welcome to our next session.

Seekingalpha | 11 months ago
All You Need to Know About Centene (CNC) Rating Upgrade to Strong Buy

All You Need to Know About Centene (CNC) Rating Upgrade to Strong Buy

Centene (CNC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Loading...
Load More